Pentixapharm Holding AG (FRA:PTP)
1.934
-0.016 (-0.82%)
At close: Aug 8, 2025, 10:00 PM CET
Pentixapharm Holding AG Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 14.21 | 23.23 | 9.7 | 1.09 | 2.39 |
Short-Term Investments | - | - | 0.53 | - | - |
Cash & Short-Term Investments | 14.21 | 23.23 | 10.23 | 1.09 | 2.39 |
Cash Growth | 14.11% | 127.05% | 842.17% | -54.50% | - |
Accounts Receivable | 0.04 | 6.81 | 0.16 | 0.51 | 0.01 |
Other Receivables | 0.18 | 0.91 | 8.32 | 2.25 | 0.16 |
Receivables | 0.22 | 7.71 | 8.48 | 2.77 | 0.17 |
Other Current Assets | 1.82 | 0.34 | - | - | - |
Total Current Assets | 16.24 | 31.28 | 18.71 | 3.85 | 2.56 |
Property, Plant & Equipment | 0.25 | 0.27 | 0.32 | 0.33 | 0.26 |
Long-Term Investments | - | - | - | - | 1.32 |
Goodwill | - | - | 0.78 | 0.78 | - |
Other Intangible Assets | 34.11 | 35.35 | 0.81 | 0.88 | 0.95 |
Long-Term Deferred Tax Assets | - | - | 1.79 | 1.79 | - |
Long-Term Deferred Charges | - | - | 50.98 | 46.23 | 24.06 |
Other Long-Term Assets | 0.48 | 0.48 | 0.01 | 0.01 | - |
Total Assets | 51.09 | 67.39 | 73.4 | 53.88 | 29.15 |
Accounts Payable | 1.5 | 8.94 | 2.54 | 0.21 | 0.4 |
Accrued Expenses | - | 0.6 | 0.35 | 0.3 | 0.07 |
Current Income Taxes Payable | - | 0.08 | - | - | - |
Current Unearned Revenue | - | 4.21 | 5.08 | - | - |
Other Current Liabilities | 4.84 | 0.21 | 1.43 | 1.34 | 0.03 |
Total Current Liabilities | 6.34 | 14.04 | 9.4 | 1.84 | 0.5 |
Long-Term Debt | - | - | 6.3 | 6.11 | - |
Long-Term Unearned Revenue | - | - | 0.34 | - | - |
Long-Term Deferred Tax Liabilities | 3.73 | 3.93 | 8.88 | 7.45 | 0.76 |
Other Long-Term Liabilities | 0 | 0 | 0 | 0 | - |
Total Liabilities | 10.07 | 17.97 | 24.92 | 15.41 | 1.26 |
Common Stock | 24.8 | 24.8 | 21.7 | 0.09 | 0.09 |
Retained Earnings | -21.25 | -12.84 | 2.13 | -0.3 | -4.45 |
Treasury Stock | -0.01 | -0.01 | - | - | - |
Comprehensive Income & Other | 37.47 | 37.48 | 24.65 | 38.68 | 32.25 |
Shareholders' Equity | 41.01 | 49.42 | 48.48 | 38.47 | 27.88 |
Total Liabilities & Equity | 51.09 | 67.39 | 73.4 | 53.88 | 29.15 |
Total Debt | - | - | 6.3 | 6.11 | - |
Net Cash (Debt) | 14.21 | 23.23 | 3.93 | -5.03 | 2.39 |
Net Cash Growth | 14.11% | 490.54% | - | - | - |
Net Cash Per Share | 0.57 | 0.94 | 0.18 | - | - |
Filing Date Shares Outstanding | 24.78 | 24.78 | 21.7 | - | - |
Total Common Shares Outstanding | 24.78 | 24.78 | 21.7 | - | - |
Working Capital | 9.91 | 17.24 | 9.31 | 2.01 | 2.06 |
Book Value Per Share | 1.65 | 1.99 | 2.23 | - | - |
Tangible Book Value | 6.91 | 14.06 | 46.9 | 36.81 | 26.94 |
Tangible Book Value Per Share | 0.28 | 0.57 | 2.16 | - | - |
Machinery | - | - | 0.48 | 0.44 | 0.33 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.